US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

243.50

+20.509.19%

Volume:527.55K

Turnover:125.80M

Market Cap:639.07M

PE:- -

High:246.22

Open:223.71

Low:222.88

Close:223.00

52wk High:341.93

52wk Low:102.35

Shares:2.62M

Float Shares:2.62M

Volume Ratio:1.18

T/O Rate:20.10%

Dividend:0.91

Dividend Rate:0.38%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

U.S. Food and Drug Administration Awards Additional Funding for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations

Analysts Are Bullish on Top Healthcare Stocks: RegenXBio (RGNX), Benitec Biopharma (BNTC)

National Healthcare Properties says has LOIs for $244M of SHOP acquisitions

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Neogen (NEOG), Larimar Therapeutics (LRMR) and Sagimet Biosciences, Inc. Class A (SGMT)

Zymeworks sees FY26 revenue $278M-$292M, consensus $304.04M

India’s Top Court Clears Independent Forensic Audit of IHH’s Fortis Unit, Limits Impact of Delhi Ruling

Court Dismisses Molina Healthcare Securities Fraud Complaint, Allows Plaintiff to Amend

Man Group PLC : Form 8.3 - Spire Healthcare Group Plc

Dezhan Healthcare's Subsidiary Receives FDA Approval for Clinical Trial of Innovative Drug WYY026B Injection

Jianyou Pharmaceutical's Subsidiary Gains US FDA Approval for Vitamin B1 Injection Product

Incyte, Mirum's Treatment of Rare Genetic Ossification Condition Approved by US FDA

MT Newswires Live

Amvis to Launch AI-Focused Subsidiary AIZIA to Boost Healthcare Productivity

Austco Director Increases Shareholding After Performance Rights Vesting

Healthcare & Medical Investment Corp Secures Social Loan for 800 Million Yen Refinancing

Austco Healthcare Issues 2.7 Million New Shares on Conversion of Unquoted Securities

DKSH Expands Grünenthal Pain Management Partnership Across Eight Asia-Pacific Markets

Analysts Offer Insights on Healthcare Companies: Celldex (CLDX), Nanobiotix (NBTX) and Senseonics Holdings (SENS)

Lupin Wins U.S. FDA Tentative Nod for Novel Apixaban Oral Suspension

Zydus Lifesciences' US Office FDA Inspection Ends With No Observations

MT Newswires Live

EBR Systems Says US FDA Completes Inspection of New California Facility; Shares Up 4%

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/LABU/news?page=20"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":243.5,"timestamp":1791570042007,"preClose":223,"halted":0,"volume":527547,"delay":0,"changeRate":0.09192825112107623,"floatShares":2624500,"shares":2624500,"eps":0,"marketStatus":"Trading","change":20.5,"latestTime":"10-09 14:20:48 EDT","open":223.71,"high":246.22,"low":222.88,"amount":125803262.63745,"amplitude":0.104664,"askPrice":244,"askSize":1,"bidPrice":243.37,"bidSize":230,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791576000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":223,"sharesOutstanding":3074486,"nav":227.52,"aum":597123938.28,"dividendRate":0.003755,"bidAskSpread":0.003146,"preHourTrading":{"tag":"盘前","latestPrice":223.28,"preClose":223,"latestTime":"09:28 EDT","volume":2212,"amount":498293.87776,"timestamp":1791552512789,"change":0.28,"changeRate":0.001256,"amplitude":0.01487},"postHourTrading":{"tag":"盘后","latestPrice":223.66,"preClose":223,"latestTime":"19:57 EDT","volume":4124,"amount":918785.7173,"timestamp":1791503872443,"change":0.66,"changeRate":0.00296,"amplitude":0.008427},"volumeRatio":1.179371,"impliedVol":0.9831,"impliedVolPercentile":0.753},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2624500,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.179371,"shares":2624500,"dividePrice":0.9143,"high":246.22,"amplitude":0.104664,"preClose":223,"low":222.88,"week52Low":102.3547,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":243.5,"committee":0.991342,"eps":0,"divideRate":0.003755,"volume":527547,"delay":0,"ttmEps":0,"open":223.71,"prevYearClose":159.39,"prevWeekClose":248.72,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":248.72,"twentyDayClose":261.3,"sixtyDayClose":254.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:20,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670234567","title":"U.S. Food and Drug Administration Awards Additional Funding for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations","url":"https://stock-news.laohu8.com/highlight/detail?id=2670234567","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670234567?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:30","pubTimestamp":1790595000,"startTime":"0","endTime":"0","summary":"NDA submission completed following positive Phase 3 SELVA results; potential U.S. commercial launch in the first half of 2027, if approved QTORIN rapamycin has the potential to become the first FDA-ap","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/28/3369784/0/en/u-s-food-and-drug-administration-awards-additional-funding-for-qtorin-rapamycin-for-the-treatment-of-microcystic-lymphatic-malformations.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","BMED","IDNA","MEDX","NVIB","HYLG","BK4585","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670239323","title":"Analysts Are Bullish on Top Healthcare Stocks: RegenXBio (RGNX), Benitec Biopharma (BNTC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670239323","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670239323?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:30","pubTimestamp":1790591429,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on RegenXBio (RGNX), Benitec Biopharma (BNTC) and Vaxcy...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-regenxbio-rgnx-benitec-biopharma-bntc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-regenxbio-rgnx-benitec-biopharma-bntc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4505","BK4563","LABU","RGNX","LU0128526141.USD","LU0029874061.USD","XLV","BK4585","BK4139","BK4588","XBI","BK4581","HCSG","BNTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670239368","title":"National Healthcare Properties says has LOIs for $244M of SHOP acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2670239368","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670239368?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:25","pubTimestamp":1790591155,"startTime":"0","endTime":"0","summary":"The company currently has signed purchase and sale agreements or non-binding letters of intent for approximately $244M of SHOP acquisitions, compri...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/national-healthcare-properties-says-has-lois-for-244m-of-shop-acquisitions-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/national-healthcare-properties-says-has-lois-for-244m-of-shop-acquisitions-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0390134368.USD","BK4551","LU1435385759.SGD","LU1861558580.USD","LU1861559042.SGD","BK4225","BK4528","LU1548497426.USD","LU1429558221.USD","BK4116","LU2265009873.SGD","NHP","XBI","SHPD","XLV","LU0081259029.USD","BK4585","LU1623119135.USD","BK4581","BK4613","LU1712237335.SGD","LU2326559502.SGD","SHOP","BK4532","LU1720051017.SGD","LU1691799644.USD","BK4548","LU2357305700.SGD","LU0823421416.USD","LABU","LU1804176565.USD","BK4524","SHPU","LU0823421333.USD","BK4588","LU1720051108.HKD","BK4566","LU2063271972.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670398762","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Neogen (NEOG), Larimar Therapeutics (LRMR) and Sagimet Biosciences, Inc. Class A (SGMT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670398762","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670398762?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:20","pubTimestamp":1790590815,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Neogen (NEOG), Larimar Therapeutics (LRMR) and Sagimet Bioscience...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-neogen-neog-larimar-therapeutics-lrmr-and-sagimet-biosciences-inc-class-a-sgmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-neogen-neog-larimar-therapeutics-lrmr-and-sagimet-biosciences-inc-class-a-sgmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4139","BK4198","LRMR","NEOG","BK4137","BK4581","BK4585","BK4588","HCSG","LABU","LU0128526141.USD","XBI","SGMT","LU2211817866.USD","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670236928","title":"Zymeworks sees FY26 revenue $278M-$292M, consensus $304.04M","url":"https://stock-news.laohu8.com/highlight/detail?id=2670236928","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670236928?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:10","pubTimestamp":1790590220,"startTime":"0","endTime":"0","summary":"With the completion of the Theravance Biopharma acquisition and the receipt of the U.S. FDA approval of Ziihera for first-line HER2-positive advanc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zymeworks-sees-fy26-revenue-278m-292m-consensus-304-04m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zymeworks-sees-fy26-revenue-278m-292m-consensus-304-04m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","BK4588","TECB","LABU","MRNX","XLVX","TBXU","PSCH","BK4007","PINK","GDOC","IEIH","BK4585","IYH","BMED","RSPH","LFSC","TBPH","BBP","MEDI","IBB","NVIB","SYNB","MRNY","FRTY","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670235109","title":"India’s Top Court Clears Independent Forensic Audit of IHH’s Fortis Unit, Limits Impact of Delhi Ruling","url":"https://stock-news.laohu8.com/highlight/detail?id=2670235109","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670235109?lang=en_us&edition=fundamental","pubTime":"2026-09-28 17:57","pubTimestamp":1790589456,"startTime":"0","endTime":"0","summary":"IHH Healthcare Bhd ( ($IHHHF) ) has issued an update. IHH Healthcare Berhad disclosed that the Supreme Court of India has disposed of a Special Lea...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/indias-top-court-clears-independent-forensic-audit-of-ihhs-fortis-unit-limits-impact-of-delhi-ruling?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/indias-top-court-clears-independent-forensic-audit-of-ihhs-fortis-unit-limits-impact-of-delhi-ruling?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","MNDmain","BK4581","XBI","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670246233","title":"Court Dismisses Molina Healthcare Securities Fraud Complaint, Allows Plaintiff to Amend","url":"https://stock-news.laohu8.com/highlight/detail?id=2670246233","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670246233?lang=en_us&edition=fundamental","pubTime":"2026-09-28 17:26","pubTimestamp":1790587564,"startTime":"0","endTime":"0","summary":"A federal judge has dismissed the consolidated securities fraud complaint against Molina Healthcare ($MOH) and two of its executives, while allowin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/court-dismisses-molina-healthcare-securities-fraud-complaint-allows-plaintiff-to-amend?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/court-dismisses-molina-healthcare-securities-fraud-complaint-allows-plaintiff-to-amend?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MOH","SG9999014039.USD","LABU","BK4585","SG9999014021.USD","BK4154","BK4532","BK4581","SG9999014013.SGD","XBI","SG9999014005.SGD","XLV","BK4588","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670391233","title":"Man Group PLC : Form 8.3 - Spire Healthcare Group Plc","url":"https://stock-news.laohu8.com/highlight/detail?id=2670391233","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670391233?lang=en_us&edition=fundamental","pubTime":"2026-09-28 17:14","pubTimestamp":1790586840,"startTime":"0","endTime":"0","summary":"FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION (a)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/28/3369620/0/en/man-group-plc-form-8-3-spire-healthcare-group-plc.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","BK4588","LABU","BK4585","BK4581","XBI","HCSG","BK4137","LU0029874061.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112995199","title":"Dezhan Healthcare's Subsidiary Receives FDA Approval for Clinical Trial of Innovative Drug WYY026B Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1112995199","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112995199?lang=en_us&edition=fundamental","pubTime":"2026-09-28 17:10","pubTimestamp":1790586629,"startTime":"0","endTime":"0","summary":"Dezhan Healthcare Company Limited (000813.SZ) has announced that its wholly-owned subsidiary, Beijing Honghui Xin Pharmaceutical Technology Co., Ltd., recently received notification from the U.S....","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0114","BK0060","BMED","MEDX","LNGR","LABU","PSYK","IBBQ","BK4585","BK1574","06978","IBBJ","000813","BK1161","BK0239","159992","MDTX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185130345","title":"Jianyou Pharmaceutical's Subsidiary Gains US FDA Approval for Vitamin B1 Injection Product","url":"https://stock-news.laohu8.com/highlight/detail?id=1185130345","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185130345?lang=en_us&edition=fundamental","pubTime":"2026-09-28 16:40","pubTimestamp":1790584825,"startTime":"0","endTime":"0","summary":"Jianyou Pharmaceutical (603707.SH) has announced that its subsidiary, Hong Kong Jianyou Industrial Co., Ltd. (\"Hong Kong Jianyou\"), recently received an ANDA approval notice (ANDA number: 213131)...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK0046","BK0239","603707","BK0186","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670428776","title":"Incyte, Mirum's Treatment of Rare Genetic Ossification Condition Approved by US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2670428776","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670428776?lang=en_us&edition=fundamental","pubTime":"2026-09-28 16:25","pubTimestamp":1790583903,"startTime":"0","endTime":"0","summary":"Incyte  and Mirum Pharmaceuticals'  Atebrioz tablet has been approved by the US Food and Drug Administration to treat adult and pediatric patients aged 12 years and older with fibrodysplasia ossificans progressiva, the companies said Friday.The disease is a very rare genetic disease in which bone forms in muscles, tendons, ligaments and other soft tissues, progressively restricting movements. The drug reduces the volume of new ossification, they said.The drug, developed by Incyte and licensed to Mirum Pharmaceuticals, is expected to be available in the US in November, the companies said.The FDA also granted Incyte a rare pediatric disease priority review voucher which can be used in a later application, the companies said.The European Union is also now reviewing a marketing authorization application for the drug, the companies said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4550","BK4532","BK4588","MIRM","BK4585","INCY","LABU","IDNA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670287464","title":"Amvis to Launch AI-Focused Subsidiary AIZIA to Boost Healthcare Productivity","url":"https://stock-news.laohu8.com/highlight/detail?id=2670287464","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670287464?lang=en_us&edition=fundamental","pubTime":"2026-09-28 16:10","pubTimestamp":1790583012,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Amvis Holdings.Inc. ( ($JP:7071) ). Amvis Holdings, Inc. has resolved to establish AIZIA, Inc. as a wholly owne...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amvis-to-launch-ai-focused-subsidiary-aizia-to-boost-healthcare-productivity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amvis-to-launch-ai-focused-subsidiary-aizia-to-boost-healthcare-productivity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU0128526141.USD","BK4588","AIPO","XBI","QTOC","XLV","VTHR","BK4585","ARTY","CHAT","LU0029874061.USD","LABU","BK4137","AGIX","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670284100","title":"Austco Director Increases Shareholding After Performance Rights Vesting","url":"https://stock-news.laohu8.com/highlight/detail?id=2670284100","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670284100?lang=en_us&edition=fundamental","pubTime":"2026-09-28 15:01","pubTimestamp":1790578860,"startTime":"0","endTime":"0","summary":"Austco Healthcare Limited ( ($AU:AHC) ) has issued an announcement. Austco Healthcare Limited has disclosed a change in the holdings of director Cl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/austco-director-increases-shareholding-after-performance-rights-vesting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/austco-director-increases-shareholding-after-performance-rights-vesting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4588","XLV","BK4585","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670831284","title":"Healthcare & Medical Investment Corp Secures Social Loan for 800 Million Yen Refinancing","url":"https://stock-news.laohu8.com/highlight/detail?id=2670831284","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670831284?lang=en_us&edition=fundamental","pubTime":"2026-09-28 14:55","pubTimestamp":1790578530,"startTime":"0","endTime":"0","summary":"An announcement from Healthcare & Medical Investment Corp ( ($JP:3455) ) is now available. Healthcare & Medical Investment Corporation has arranged...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/healthcare-medical-investment-corp-secures-social-loan-for-800-million-yen-refinancing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/healthcare-medical-investment-corp-secures-social-loan-for-800-million-yen-refinancing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","XLV","LABU","BK4581","LU0029874061.USD","BK4588","BK4585","HCSG","XBI","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670602281","title":"Austco Healthcare Issues 2.7 Million New Shares on Conversion of Unquoted Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2670602281","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670602281?lang=en_us&edition=fundamental","pubTime":"2026-09-28 14:37","pubTimestamp":1790577470,"startTime":"0","endTime":"0","summary":"Austco Healthcare Limited ( ($AU:AHC) ) has shared an announcement. Austco Healthcare Limited has notified the market that 2,730,877 ordinary fully...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/austco-healthcare-issues-2-7-million-new-shares-on-conversion-of-unquoted-securities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/austco-healthcare-issues-2-7-million-new-shares-on-conversion-of-unquoted-securities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","HCSG","BK4588","BK4137","LABU","BK4581","LU0029874061.USD","LU0128526141.USD","XLV","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670286106","title":"DKSH Expands Grünenthal Pain Management Partnership Across Eight Asia-Pacific Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2670286106","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670286106?lang=en_us&edition=fundamental","pubTime":"2026-09-28 13:33","pubTimestamp":1790573585,"startTime":"0","endTime":"0","summary":"DKSH Holding AG ( ($CH:DKSH) ) has provided an announcement. DKSH’s Healthcare unit has expanded its collaboration with Grünenthal, a global leader...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dksh-expands-grunenthal-pain-management-partnership-across-eight-asia-pacific-markets?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dksh-expands-grunenthal-pain-management-partnership-across-eight-asia-pacific-markets?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4581","BK4585","XLV","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670165285","title":"Analysts Offer Insights on Healthcare Companies: Celldex (CLDX), Nanobiotix (NBTX) and Senseonics Holdings (SENS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670165285","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670165285?lang=en_us&edition=fundamental","pubTime":"2026-09-28 12:40","pubTimestamp":1790570421,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Celldex (CLDX), Nanobiotix (NBTX) and Senseonics Hol...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-celldex-cldx-nanobiotix-nbtx-and-senseonics-holdings-sens-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-celldex-cldx-nanobiotix-nbtx-and-senseonics-holdings-sens-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BK4588","CLDX","BK4139","XLV","LU0029874061.USD","BK4585","HCSG","NBTX","XBI","SENS","BK4137","LABU","BK4581","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670285199","title":"Lupin Wins U.S. FDA Tentative Nod for Novel Apixaban Oral Suspension","url":"https://stock-news.laohu8.com/highlight/detail?id=2670285199","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670285199?lang=en_us&edition=fundamental","pubTime":"2026-09-28 12:34","pubTimestamp":1790570051,"startTime":"0","endTime":"0","summary":"Lupin Limited ( ($IN:LUPIN) ) has issued an announcement. Lupin Limited has secured tentative approval from the U.S. FDA for its Apixaban Oral Susp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lupin-wins-u-s-fda-tentative-nod-for-novel-apixaban-oral-suspension?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lupin-wins-u-s-fda-tentative-nod-for-novel-apixaban-oral-suspension?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670229288","title":"Zydus Lifesciences' US Office FDA Inspection Ends With No Observations","url":"https://stock-news.laohu8.com/highlight/detail?id=2670229288","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670229288?lang=en_us&edition=fundamental","pubTime":"2026-09-28 11:07","pubTimestamp":1790564876,"startTime":"0","endTime":"0","summary":"Zydus Lifesciences (BOM:532321, NSE:ZYDUSLIFE) said a U.S. Food and Drug Administration inspection of its pharmacovigilance and post-marketing surveillance system at its New Jersey office concluded with no observations, according to a Saturday exchange filing.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670055400","title":"EBR Systems Says US FDA Completes Inspection of New California Facility; Shares Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670055400","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670055400?lang=en_us&edition=fundamental","pubTime":"2026-09-28 10:22","pubTimestamp":1790562130,"startTime":"0","endTime":"0","summary":"EBR Systems  said the US Food and Drug Administration  has completed its inspection of the company's new California manufacturing facility, according to a Monday filing with the Australian bourse.The inspection was carried out in relation to the company's pre-market approval supplement to add the facility as a manufacturing site for the WiSE System, its lead-less left ventricular endocardial pacing device designed for cardiac resynchronization therapy in heart failure patients, the filing said.The US FDA investigator issued a Form FDA 483 listing two routine observations, which the company has \"promised to correct.\"Facility approval is anticipated by year-end, per the filing.EBR Systems shares rose 4% in morning trade Monday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","EBR.AU","LABU","BK4585","BK7007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":20,"totalSize":419,"code":"91000000","status":"200"}]}}